Global Wound Care market

The Global Wound Care Market Is Set to Boom, Particularly in Emerging Economies

30 March 2020
Pharma
Global Wound Care market

The global wound care market is big, and only set to grow bigger.  Currently, estimates show a CAGR of 4.6% in the years to come, with the overall market growing from US$19.8 billion in 2019 to US$24.8 billion by 2024.  The industry is ripe with opportunity, with that growth coming from several factors - but most especially growth in emerging economies and the BRICS nations.

In this article, we'll provide a brief overview of the situation.

The Scope of The Wound Care Market

The wound care market exploded with the development of antibiotics in the early 20th Century and has continued apace since.  The market now spans a wide range of products and approaches, including:

  • Medicines
  • Foams
  • Alginates
  • Hydrocolloids
  • Antimicrobial dressings
  • Sutures, staples, and tapes
  • Negative Pressure Wound Therapy (NPWT) systems
  • Diagnostic and assessment equipment

The richness of the market is one of many contributing factors to its growth, but that growth is largely being driven by global demand.

Driving Factors for Growth in The Global Wound Care Market

While wound care is doing well worldwide, there is a particular uptick in emerging economies such as the BRICS nations, as well as the Asia-Pacific region.  These areas are seeing significant increases in the diagnosis of cardiovascular disorders and diabetes, among other medical issues. 

In addition, these nations are seeing significant expansion of their highways and other infrastructure, leading to a parallel increase in injurious accidents.  At the same time, wages and standards of living are continuing to grow in these nations as well, leaving the public with more money to spend on medical services.

Combined with the vast population in these markets - over 2.5 billion people in India and China alone - and the wound care market is poised for major increases in years to come.

Overall, Asia is currently projected to see the largest gains in this industry.  There is a rising geriatric population, as well as significant increases to overall healthcare infrastructure.  Alongside, North America and Europe will still also see large increases in wound care markets, due to their high standards of living and high overall per-capita spending on healthcare.

Visiongain Brings You Insights

We compile and produce highly detailed reports spanning eighteen major global industries and dozens of subsidiary markets.  From biomedical to aerospace, look to Visiongain for the insights your business needs to plan for the future.

Click here to browse our medical market report library.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever